IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Abroad (travel likely)RecruitingPHASE1

Conditions

B-cell Non-Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma · Follicular Lymphoma · Mantle Cell Lymphoma · B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Maryland Baltimore, Baltimore, Maryland, United States

  • Westmead Hospital, Westmead, New South Wales, Australia

    Contact: Principal Investigator (Amanda Johnston, MD)
  • Royal Adelaide Hospital, Adelaide, South Australia, Australia

    Contact: Study coordinator (Pratyush Giri, MBBS)
    Contact: Principal Investigator (Pratyush Giri, MBBS)
  • Royal Hobart Hospital, Hobart, Tasmania, Australia

    Contact: Principal Investigator (Rosemary Harrup, MD)
  • Linear Clinical Research, Perth, Western Australia, Australia

    Contact: Study coordinator (Katharine Lewis, MD)
    Contact: Principal Investigator (Katharine Lewis, MD)
  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Sarit Assouline, MD)
    Contact: Principal Investigator (Sarit Assouline, MD)
  • La Fondazione e l'Istituto di Candiolo, Candiolo, Italy

    Contact: Study coordinator (Umberto Vitolo, M.D.)
    Contact: Principal Investigator (Umberto Vitolo, M.D.)
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Andres Jose Maria Ferreri, M.D.)
    Contact: Principal Investigator (Andres Jose Maria Ferreri, M.D.)
  • Istituto Europeo Clinico Humanitas, Milan, Italy

    Contact: Study coordinator (Carmelo Carlo-Stella, M.D.)
    Contact: Principal Investigator (Carmelo Carlo-Stella, M.D.)
  • Istituto Europeo di Oncologia, Milan, Italy

    Contact: Study coordinator (Enrico Derenzini, M.D.)
    Contact: Principal Investigator (Enrico Derenzini, M.D.)
  • Institut Catala D'Oncologia, Badalona, Spain

    Contact: Study coordinator (Mireia Franch-Sarto, M.D.)
    Contact: Principal Investigator (Mireia Franch-Sarto, M.D.)
  • Hospital Universitario Quironsalud Madrid, Madrid, Spain

    Contact: Study coordinator (Maria del Carmen Martinez-Chamorro, M.D.)
    Contact: Principal Investigator (Maria del Carmen Martinez-Chamorro, M.D.)
  • Hospital Clinico Universitario de Salamanca, Salamanca, Spain

    Contact: Study coordinator (Alejandro Martin Garcia-Sancho, M.D.)
    Contact: Principal Investigator (Alejandro Martin Garcia-Sancho, M.D.)
Study leads
  • Paul I Nadler, MD

    Study Director

    Iksuda Therapeutics